InnovAge Holding Corp. Announces $5.0 Million Share Repurchase Program

Published on June 10, 2024

DENVER, June 10, 2024 (GLOBE NEWSWIRE) -- InnovAge Holding Corp. (NASDAQ: INNV) (the “Company” or “InnovAge”) announced today that its Board of Directors has approved a share repurchase program (the “Program”) that authorizes the Company to repurchase up to $5.0 million of its common stock.

Continue reading on website
Other news

IP Considerations for Gene Editing in the Cell Therapy space

June 10, 2024
In this article, Cellistic's Head of IP, Sergei Kurkin, addresses the critical intellectual property (IP) considerations in the rapidly evolving field of gene editing for cell therapies, including induced pluripotent stem cell (iPSC) derived therapies. The two main elements of IP strategy highlighted are: Freedom to Operate (FTO): Ensuring that the use of a technology does not infringe on exist

Accelerating Early Phase Biologics from the Clinic to Commercialization

June 12, 2024
Webinar OverviewIn this webinar, experts Abzena and Sartorius discuss the important role that key technologies and processes play in expediting an early-phase biologics path to the clinic and beyond will be discussed.The mammalian cell-based biomanufacturing industry continues to lead the market for biologics. These include monoclonal antibodies (mAbs), fusion proteins, antibody fragments, bispeci